CollPlant Biotechnologies Ltd Adjustments to Additional Paid in Capital, Income Tax Benefit from Share-based Compensation
CollPlant Biotechnologies Ltd (CLGN) reported Adjustments to Additional Paid in Capital, Income Tax Benefit from Share-based Compensation of $1.60 million for the 12-month period ending 2021-12-31, per its 20-F filed 2022-03-24.
Discontinued › Notes › Compensation Related Costs
us-gaap:AdjustmentsToAdditionalPaidInCapitalTaxEffectFromShareBasedCompensation · last filed 2022-03-24
- CollPlant Biotechnologies Ltd adjustments to additional paid in capital, income tax benefit from share-based compensation for the quarter ending 2021-06-30 was $469.00K, a 1.68% decline year-over-year.
- CollPlant Biotechnologies Ltd adjustments to additional paid in capital, income tax benefit from share-based compensation for the quarter ending 2020-06-30 was $477.00K, a 65.05% increase year-over-year.
- CollPlant Biotechnologies Ltd adjustments to additional paid in capital, income tax benefit from share-based compensation for the quarter ending 2019-06-30 was $289.00K.
| Period end | Adjustments to Additional Paid in Capital, Income Tax Benefit from Share-based Compensation 3 month | Adjustments to Additional Paid in Capital, Income Tax Benefit from Share-based Compensation 6 month | Adjustments to Additional Paid in Capital, Income Tax Benefit from Share-based Compensation 12 month |
|---|---|---|---|
| 2021-12-31 | $1.60M 20-F · filed 2022-03-24 | ||
| 2021-06-30 | $469.00K 6-K · filed 2021-08-19 | $954.00K 6-K · filed 2021-08-19 | |
| 2020-12-31 | $1.60M 20-F · filed 2022-03-24 | ||
| 2020-06-30 | $477.00K 6-K · filed 2021-08-19 | $794.00K 6-K · filed 2021-08-19 | |
| 2019-12-31 | $1.13M 20-F · filed 2022-03-24 | ||
| 2019-06-30 | $289.00K 6-K · filed 2020-08-28 | ||
| 2018-12-31 | $1.00M 20-F · filed 2021-03-26 |